9-2729470-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_133497.4(KCNV2):c.1381G>A(p.Gly461Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000251 in 1,613,746 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_133497.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNV2 | NM_133497.4 | c.1381G>A | p.Gly461Arg | missense_variant | 2/2 | ENST00000382082.4 | NP_598004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNV2 | ENST00000382082.4 | c.1381G>A | p.Gly461Arg | missense_variant | 2/2 | 1 | NM_133497.4 | ENSP00000371514 | P1 | |
PUM3 | ENST00000490444.2 | c.*127-8938C>T | intron_variant, NMD_transcript_variant | 5 | ENSP00000474467 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251346Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135844
GnomAD4 exome AF: 0.000262 AC: 383AN: 1461642Hom.: 1 Cov.: 31 AF XY: 0.000228 AC XY: 166AN XY: 727128
GnomAD4 genome AF: 0.000145 AC: 22AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74288
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 461 of the KCNV2 protein (p.Gly461Arg). This variant is present in population databases (rs149648640, gnomAD 0.03%). This missense change has been observed in individual(s) with cone dystrophy with supernormal rod electroretinogram (PMID: 17896311, 18400204). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 37247). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNV2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects KCNV2 function (PMID: 23115240). For these reasons, this variant has been classified as Pathogenic. - |
Cone dystrophy with supernormal rod response Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 23, 2018 | The KCNV2 c.1381G>A (p.Gly461Arg) missense variant has been reported in at least four studies in which it is found in a total of 15 individuals affected with retinal cone dystrophy including six homozygotes (three of whom are independent) and nine compound heterozygotes (eight of whom are indepedent) (Wissinger et al. 2008; Wissinger et al. 2011; Friedburg et al. 2011; Fujinami et al. 2013). The p.Gly461Arg variant was absent from a total of 159 controls (Wissinger et al. 2008; Wissinger et al. 2011) and is reported at a frequency of 0.00058 in the European American population of the Exome Sequencing Project. The variant is present in a conserved residue in the Gly-Tyr-Gly motif, an important functional domain in the pore region of the protein. Functional studies conducted in COS7 cells showed that the variant protein is trafficked to the membrane and likely forms heteromeric channels; however, current flow through these channels was reduced relative to that through those formed with the wild type form of the protein (Smith et al. 2012). Based on the collective evidence, the p.Gly461Arg variant is classified as pathogenic for retinal cone dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Molecular Genetics, University of Zurich | Jan 30, 2021 | - - |
KCNV2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2024 | The KCNV2 c.1381G>A variant is predicted to result in the amino acid substitution p.Gly461Arg. This variant has been reported in the homozygous and compound heterozygous states in multiple individuals with retinal cone dystrophy (Thiagalingam et al. 2007. PubMed ID: 17896311; Friedburg et al. 2011. PubMed ID: 21911584; Fujinami et al. 2013. PubMed ID: 23885164; Table S2 in Weisschuh et al. 2020. PubMed ID: 32531858; Supplementary Data in Lin S et al 2024. PubMed ID: 38219857; Table S3 in Suga A et al 2022. PubMed ID: 36284460). This variant is reported in 0.024% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant has been classified as pathogenic or likely pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/37247). Given the evidence, we interpret c.1381G>A (p.Gly461Arg) as pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Mar 25, 2019 | - - |
Nystagmus;C0497552:Abnormality of the nervous system Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jan 24, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at